Abstract | INTRODUCTION: Portal vein thrombosis (PVT) is caused by local and systemic prothrombotic risk factors. In this case-control study, we evaluated the use of the Factor VIIa- antithrombin complex (FVIIa-AT) complex assay as a hypercoagulability marker in patients with PVT. METHODS: Two different groups of cases were considered: (i) n = 12 noncirrhotic PVT patients, (ii) n = 33 cirrhotic patients with PVT. Controls were sex and age-matched healthy volunteers and cirrhotic subjects without PVT, respectively. RESULTS: Levels of the FVIIa-AT complex were significantly higher in noncirrhotic PVT subjects (132 ± 32 pM) than in healthy volunteers (108 ± 18 pM, P = 0.04). No significant difference in FVIIa-AT complexes was seen between cirrhotic patients with (64 ± 20 pM) or without (61 ± 24 pM) PVT. A linear correlation was seen between FVIIa-AT and FVIIa in noncirrhotic PVT subjects. In cirrhotic patients, FVIIa-AT complexes depended on both FVIIa and AT. CONCLUSION: These results confirm the utility of the FVIIa-AT assay in identifying the hypercoagulable state of noncirrhotic patients because of a previous thrombotic event.
|
Authors | V Rossetto, L Spiezia, M Senzolo, K Rodriguez, S Gavasso, B Woodhams, P Simioni |
Journal | International journal of laboratory hematology
(Int J Lab Hematol)
Vol. 35
Issue 1
Pg. 101-5
(Feb 2013)
ISSN: 1751-553X [Electronic] England |
PMID | 22958499
(Publication Type: Journal Article)
|
Copyright | © 2012 Blackwell Publishing Ltd. |
Chemical References |
- Biomarkers
- Antithrombin III
- Factor VIIa
|
Topics |
- Adult
- Aged
- Antithrombin III
(analysis)
- Biomarkers
(blood)
- Blood Coagulation
- Case-Control Studies
- Enzyme-Linked Immunosorbent Assay
- Factor VIIa
(analysis)
- Female
- Humans
- Liver Cirrhosis
(complications)
- Male
- Middle Aged
- Portal Vein
(pathology)
- Retrospective Studies
- Thrombophilia
(physiopathology)
- Up-Regulation
- Venous Thrombosis
(blood, complications, pathology, physiopathology)
- Young Adult
|